SEARCH

SEARCH BY CITATION

References

  • Aguado-Llera D., Arilla-Ferreiro E., Campos-Barros A., Puebla-Jimenez L. and Barrios V. (2005) Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of beta-amyloid-treated rats. J. Neurochem. 92, 607615.
  • Akiyama H., Barger S., Barnum S. et al. (2000) Inflammation and Alzheimer’s disease. Neurobiol. Aging 21, 383421.
  • Alkam T., Nitta A., Mizoguchi H., Saito K., Seshima M., Itoh A., Yamada K. and Nabeshima T. (2008) Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice. Behav. Brain Res. 189, 100106.
  • Backstrom J. R., Lim G. P., Cullen M. J. and Tokes Z. A. (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 16, 79107919.
  • Bakalash S., Kipnis J., Yoles E. and Schwartz M. (2002) Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Invest. Ophthalmol. Vis. Sci. 43, 26482653.
  • Bakalash S., Shlomo G. B., Aloni E., Shaked I., Wheeler L., Ofri R. and Schwartz M. (2005) T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure. J. Mol. Med. 83, 904916.
  • Banerjee R., Mosley R. L., Reynolds A. D., Dhar A., Jackson-Lewis V., Gordon P. H., Przedborski S. and Gendelman H. E. (2008) Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE 3, e2740.
  • Brionne T. C., Tesseur I., Masliah E. and Wyss-Coray T. (2003) Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 11331145.
  • Butovsky O., Koronyo-Hamaoui M., Kunis G., Ophir E., Landa G., Cohen H. and Schwartz M. (2006) Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 1178411789.
  • Butovsky O., Kunis G., Koronyo-Hamaoui M. and Schwartz M. (2007) Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer’s disease model. Eur. J. Neurosci. 26, 413416.
  • Cao C., Arendash G. W., Dickson A., Mamcarz M. B., Lin X. and Ethell D. W. (2009) Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer’s mice without infiltrating the CNS. Neurobiol. Dis. 34, 6370.
  • Chiba T., Yamada M., Sasabe J., Terashita K., Shimoda M., Matsuoka M. and Aiso S. (2008) Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol. Psychiatry 14, 206222.
  • Deb S., Wenjun Zhang J. and Gottschall P. E. (2003) Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res. 970, 205213.
  • DeWitt D. A., Silver J., Canning D. R. and Perry G. (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer’s disease. Exp. Neurol. 121, 149152.
  • El Khoury J. and Luster A. D. (2008) Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications. Trends Pharmacol. Sci. 29, 626632.
  • El Khoury J., Toft M., Hickman S. E., Means T. K., Terada K., Geula C. and Luster A. D. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432438.
  • Fawcett J. W. and Asher R. A. (1999) The glial scar and central nervous system repair. Brain Res. Bull. 49, 377391.
  • Ferguson T. A. and Muir D. (2000) MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell. Neurosci. 16, 157167.
  • Fiala M., Cribbs D. H., Rosenthal M. and Bernard G. (2007) Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer’s disease. J. Alzheimer’s Dis. 11, 457463.
  • Fisher J., Levkovitch-Verbin H., Schori H., Yoles E., Butovsky O., Kaye J. F., Ben-Nun A. and Schwartz M. (2001) Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J. Neurosci. 21, 136142.
  • Ford A. L., Goodsall A. L., Hickey W. F. and Sedgwick J. D. (1995) Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154, 43094321.
  • Ford A. L., Foulcher E., Lemckert F. A. and Sedgwick J. D. (1996) Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184, 17371745.
  • Frenkel D., Huang Z., Maron R., Koldzic D. N., Moskowitz M. A. and Weiner H. L. (2005a) Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 233, 125132.
  • Frenkel D., Maron R., Burt D. S. and Weiner H. L. (2005b) Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest. 115, 24232433.
  • Garcia-Alloza M., Borrelli L. A., Rozkalne A., Hyman B. T. and Bacskai B. J. (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 102, 10951104.
  • Gasparini L. and Xu H. (2003) Potential roles of insulin and IGF-1 in Alzheimer’s disease. Trends Neurosci. 26, 404406.
  • Glenner G. G., Wong C. W., Quaranta V. and Eanes E. D. (1984) The amyloid deposits in Alzheimer’s disease: their nature and pathogenesis. Appl. Pathol. 2, 357369.
  • Gottschall P. E. and Deb S. (1996) Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3, 6975.
  • Hampel H., Teipel S. J., Fuchsberger T. et al. (2004) Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer’s disease in patients with mild cognitive impairment. Mol. Psychiatry 9, 705710.
  • Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353356.
  • Hauben E., Butovsky O., Nevo U. et al. (2000a) Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20, 64216430.
  • Hauben E., Nevo U., Yoles E. et al. (2000b) Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355, 286287.
  • Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L. and Schwartz M. (2001) Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 108, 591599.
  • Hauben E., Gothilf A., Cohen A., Butovsky O., Nevo U., Smirnov I., Yoles E., Akselrod S. and Schwartz M. (2003) Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J. Neurosci. 23, 88088819.
  • Hawkes C. A. and McLaurin J. (2009) Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl Acad. Sci. USA 106, 12611266.
  • He J. and Crews F. T. (2007) Neurogenesis decreases during brain maturation from adolescence to adulthood. Pharmacol. Biochem. Behav. 86, 327333.
  • Hermes G., Ajioka J. W., Kelly K. A. et al. (2008) Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J. Neuroinflammation 5, 48.
  • Jankowsky J. L., Fadale D. J., Anderson J. et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159170.
  • Jarvis K., Assis-Nascimento P., Mudd L. M. and Montague J. R. (2007) Beta-amyloid toxicity and reversal in embryonic rat septal neurons. Neurosci. Lett. 423, 184188.
  • Juedes A. E. and Ruddle N. H. (2001) Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J. Immunol. 166, 51685175.
  • Juedes A. E., Hjelmstrom P., Bergman C. M., Neild A. L. and Ruddle N. H. (2000) Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 164, 419426.
  • Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I. R. and Schwartz M. (2000) T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl Acad. Sci. USA 97, 74467451.
  • Koehler N. K., Genain C. P., Giesser B. and Hauser S. L. (2002) The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study. J. Immunol. 168, 59205927.
  • Koffie R. M., Meyer-Luehmann M., Hashimoto T. et al. (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl Acad. Sci. USA 106, 40124017.
  • Lauren J., Gimbel D. A., Nygaard H. B., Gilbert J. W. and Strittmatter S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 11281132.
  • Lefterov I., Fitz N. F., Cronican A., Lefterov P., Staufenbiel M. and Koldamova R. (2009) Memory deficits in APP23/Abca1+/- mice correlate with the level of Abeta oligomers. ASN Neuro 1, e00006, doi: DOI: 10.1042/AN20090015.
  • Lewitus G. M. and Schwartz M. (2008) Behavioral immunization: immunity to self-antigens contributes to psychological stress resilience. Mol. Psychiatry 14, 532536.
  • Lewitus G. M., Ziv A. W., Gersner M. S., Zangen A. and Schwartz M. (2008) Vaccination as a Novel Approach for Treating Depressive Behavior. Biol. Psychiatry 65, 283288.
  • Li S., Hong S., Shepardson N. E., Walsh D. M., Shankar G. M. and Selkoe D. (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788801.
  • Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T. and Veltkamp R. (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192199.
  • Lutz M. B. and Schuler G. (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445449.
  • Masters C. L., Wyss-Coray T. and Pasinetti G. M. (2008) Anti-inflammatory drugs fall short in Alzheimer’s disease. Nat. Med. 14, 916.
  • Matsui F. and Oohira A. (2004) Proteoglycans and injury of the central nervous system. Congenit. Anom. (Kyoto) 44, 181188.
  • McKeon R. J., Jurynec M. J. and Buck C. R. (1999) The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19, 1077810788.
  • Mentlein R., Ludwig R. and Martensen I. (1998) Proteolytic degradation of Alzheimer’s disease amyloid beta-peptide by a metalloproteinase from microglia cells. J. Neurochem. 70, 721726.
  • Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I. R. and Schwartz M. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 4955.
  • Moreno H., Yu E., Pigino G., Hernandez A. I., Kim N., Moreira J. E., Sugimori M. and Llinas R. R. (2009) Synaptic transmission block by presynaptic injection of oligomeric amyloid beta. Proc. Natl Acad. Sci. USA 106, 59015906.
  • Nakamura H., Fujii Y., Inoki I., Sugimoto K., Tanzawa K., Matsuki H., Miura R., Yamaguchi Y. and Okada Y. (2000) Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275, 3888538890.
  • Nalivaeva N. N., Fisk L. R., Belyaev N. D. and Turner A. J. (2008) Amyloid-degrading enzymes as therapeutic targets in Alzheimer’s disease. Curr. Alzheimer Res. 5, 212224.
  • Olsson T., Diener P., Ljungdahl A., Hojeberg B., Van Der Meide P. H. and Kristensson K. (1992) Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity 13, 117126.
  • Price D. L., Whitehouse P. J. and Struble R. G. (1985) Alzheimer’s disease. Annu. Rev. Med. 36, 349356.
  • Rapalino O., Lazarov-Spiegler O., Agranov E. et al. (1998) Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4, 814821.
  • Renno T., Krakowski M., Piccirillo C., Lin J. Y. and Owens T. (1995) TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154, 944953.
  • Rolls A., Shechter R., London A., Segev Y., Jacob-Hirsch J., Amariglio N., Rechavi G. and Schwartz M. (2008) Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med. 5, e171.
  • Rolls A., Shechter R. and Schwartz M. (2009) The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 10, 235241.
  • Ryu E. K., Choe Y. S., Lee K. H., Choi Y. and Kim B. T. (2006) Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J. Med. Chem. 49, 61116119.
  • Schindowski K., Kratzsch T., Peters J. et al. (2003) Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer’s disease. Neuromolecular Med. 4, 161178.
  • Schindowski K., Peters J., Gorriz C. et al. (2006) Apoptosis of CD4+ T and natural killer cells in Alzheimer’s disease. Pharmacopsychiatry 39, 220228.
  • Schindowski K., Eckert A., Peters J., Gorriz C., Schramm U., Weinandi T., Maurer K., Frolich L. and Muller W. E. (2007) Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer’s disease-patients and T-cell hyporeactivity in an Alzheimer’s disease-mouse model: implications for immunotherapy. Neuromolecular Med. 9, 340354.
  • Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L. A. and Schwartz M. (2001) Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl Acad. Sci. USA 98, 33983403.
  • Schwartz M. and Moalem G. (2001) Beneficial immune activity after CNS injury: prospects for vaccination. J. Neuroimmunol. 113, 185192.
  • Sedgwick J. D., Schwender S., Imrich H., Dorries R., Butcher G. W. and Ter Meulen V. (1991) Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl Acad. Sci. USA 88, 74387442.
  • Selkoe D. J. (1991) Alzheimer’s disease. In the beginning. Nature 354, 432433.
  • Selkoe D. J. (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106113.
  • Shankar G. M., Li S., Mehta T. H. et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14, 837842.
  • Shao H., Sun S. L., Kaplan H. J. and Sun D. (2002) Induction of autoimmune encephalomyelitis and uveitis in B6 and (B6 × SJL) mice by peptides derived from myelin/oligodendrocyte glycoprotein. J. Neuroimmunol. 132, 117122.
  • Shechter R., London A., Varol C. et al. (2008) Essential role for myeloid derived cells in the recovery from spinal cord injury. SfN abstract 758.22/E6.
  • Shechter R., London A., Varol C. et al. (2009) Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6, e1000113.
  • Simard A. R. and Rivest S. (2006) Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer’s disease. Mol. Psychiatry 11, 327335.
  • Simard A. R., Soulet D., Gowing G., Julien J. P. and Rivest S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease. Neuron 49, 489502.
  • Smith J. P., Lal V., Bowser D., Cappai R., Masters C. L. and Ciccotosto G. D. (2009) Stimulus pattern dependence of the Alzheimer’s disease amyloid-beta 42 peptide’s inhibition of long term potentiation in mouse hippocampal slices. Brain Res. 1269, 176184.
  • Snyder E. M., Nong Y., Almeida C. G. et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 10511058.
  • Sonntag W. E., Lynch C., Thornton P., Khan A., Bennett S. and Ingram R. (2000) The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing. J. Anat. 197 (Pt 4), 575585.
  • Sotthibundhu A., Sykes A. M., Fox B., Underwood C. K., Thangnipon W. and Coulson E. J. (2008) Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J. Neurosci. 28, 39413946.
  • Talmor M., Mirza A., Turley S., Mellman I., Hoffman L. A. and Steinman R. M. (1998) Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur. J. Immunol. 28, 811817.
  • Tesseur I., Zou K., Esposito L. et al. (2006) Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J. Clin. Invest. 116, 30603069.
  • Tomidokoro Y., Harigaya Y., Matsubara E., Ikeda M., Kawarabayashi T., Okamoto K. and Shoji M. (2000) Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor. Neurosci. Lett. 292, 155158.
  • Town T. (2009) Alternative Abeta immunotherapy approaches for Alzheimer’s disease. CNS Neurol. Disord. Drug Targets 8, 114127.
  • Town T., Laouar Y., Pittenger C., Mori T., Szekely C. A., Tan J., Duman R. S. and Flavell R. A. (2008) Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14, 681687.
  • Tran M. H., Yamada K. and Nabeshima T. (2002) Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview. Peptides 23, 12711283.
  • Weiner H. L. and Frenkel D. (2006) Immunology and immunotherapy of Alzheimer’s disease. Nat. Rev. Immunol. 6, 404416.
  • Wyss-Coray T. (2006a) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 10051015.
  • Wyss-Coray T. (2006b) Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer’s. Curr. Alzheimer Res. 3, 191195.
  • Wyss-Coray T. and Mucke L. (2002) Inflammation in neurodegenerative disease–a double-edged sword. Neuron 35, 419432.
  • Wyss-Coray T., Lin C., Yan F., Yu G. Q., Rohde M., McConlogue L., Masliah E. and Mucke L. (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612618.
  • Yin K. J., Cirrito J. R., Yan P. et al. (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26, 1093910948.
  • Yoles E., Hauben E., Palgi O. et al. (2001) Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21, 37403748.
  • Zeng X. N., Sun X. L., Gao L., Fan Y., Ding J. H. and Hu G. (2007) Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol. Cell. Neurosci. 34, 3439.
  • Zhang W., Liang S., Wu J. and Horuzsko A. (2008) Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86, 11251134.
  • Zhao W., Xie W., Xiao Q., Beers D. R. and Appel S. H. (2006) Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J. Neurochem. 99, 11761187.
  • Zhao L., Lin S., Bales K. R. et al. (2009) Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J. Neurosci. 29, 36033612.
  • Zhong M. C., Kerlero de Rosbo N. and Ben-Nun A. (2002) Multiantigen/multiepitope-directed immune-specific suppression of “complex autoimmune encephalomyelitis” by a novel protein product of a synthetic gene. J. Clin. Invest. 110, 8190.
  • Ziv Y., Avidan H., Pluchino S., Martino G. and Schwartz M. (2006a) Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc. Natl Acad. Sci. USA 103, 1317413179.
  • Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J. and Schwartz M. (2006b) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 9, 268275.
  • Zuo J., Neubauer D., Graham J., Krekoski C. A., Ferguson T. A. and Muir D. (2002) Regeneration of axons after nerve transection repair is enhanced by degradation of chondroitin sulfate proteoglycan. Exp. Neurol. 176, 221228.